Expanding at a CAGR of 4.8%, the global helicobacter pylori non-invasive testing market growth is forecasted to increase from a valuation of US$ 500 million in 2023 to US$ 800 million by the end of 2033. Only urea breath tests offer accuracy in determining whether helicobacter pylori infection is active or eradicated. The Helicobacter pylori non-invasive testing market has emerged as a vital...